Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Warfarin reversal.

J P Hanley1

  • 1Department of Haematology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne UK. john.hanley@nuth.northy.nhs.uk

Journal of Clinical Pathology
|October 29, 2004
PubMed
Summary
This summary is machine-generated.

Reversing warfarin, a common oral anticoagulant, depends on the clinical situation. Serious bleeding requires rapid reversal, while minor bleeding or over-anticoagulation allows a slower approach.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of hepatitis C infection in haemophiliacs: the Edinburgh experience.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Bilateral upper limb compartment syndrome induced by strenuous exercise in a patient with haemophilia A and a low titre inhibitor.

Haemophilia : the official journal of the World Federation of Hemophilia·2015
Same author

Hyperemesis gravidarum and first trimester sagittal sinus thrombosis.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2008
Same author

Emergency warfarin reversal with prothrombin complex concentrates: UK wide study.

British journal of haematology·2008
Same author

Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature.

Haemophilia : the official journal of the World Federation of Hemophilia·2006
Same author

Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: use of a clinical scoring system to predict outcome.

Vox sanguinis·2005

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Hematology

Background:

  • Warfarin is a widely prescribed oral anticoagulant.
  • Hemorrhage is the primary side effect of warfarin therapy.
  • Effective warfarin reversal strategies are crucial for patient safety.

Purpose of the Study:

  • To review current clinical practices for warfarin reversal.
  • To discuss the factors influencing the choice of reversal method.
  • To describe the implementation of a standardized warfarin reversal protocol.

Main Methods:

  • Literature review of warfarin reversal agents and protocols.
  • Analysis of clinical scenarios dictating reversal urgency.
  • Case study of a regional warfarin reversal guideline development.

Related Experiment Videos

Main Results:

  • The urgency of warfarin reversal is dictated by the presence and severity of bleeding or the degree of over-anticoagulation.
  • Different agents and approaches exist for rapid versus gradual warfarin reversal.
  • A uniform approach to warfarin reversal was developed and described for a specific region.

Conclusions:

  • Warfarin reversal strategies must be tailored to individual patient circumstances.
  • Standardized protocols can improve the consistency and safety of warfarin reversal.
  • Further research may refine optimal reversal strategies in various clinical settings.